In 2023, the diabetes medicine use in Denmark stood at X Units (Defined Daily Dosage) Per Thousand Persons Per Day. The forecasted data from 2024 to 2028 shows a consistent increase in usage. Year-on-year, the projected growth percentages are:
- 2024: 81.9 Units (Projected)
- 2025: 6% increase to 86.8 Units
- 2026: 5.5% increase to 91.6 Units
- 2027: 5.3% increase to 96.5 Units
- 2028: 5% increase to 101.3 Units
Over the last two years (from 2023 to 2025), the average year-on-year increase stands at approximately 5.75%. The Compound Annual Growth Rate (CAGR) over the five-year forecast period from 2023 to 2028 is expected to be around 5.5%, indicating a steady rise in diabetes medicine utilization.
Future trends to watch for include advancements in diabetes treatment technology, governmental health policies, and changes in lifestyle and dietary habits that could potentially influence the rate of medicine usage. Monitoring these trends will be crucial for understanding the dynamics of diabetes management in Denmark.
